340B INDUSTRY LEADER SPOTLIGHT

Abel Haile, Senior Director, Health System Strategy & Commercial Analytics, Maxor National Pharmacy Services

Abel Haile

Q: Where did you grow up?

My family moved to the United States from Ethiopia when I was two years old, and I spent my childhood in the northwestern suburbs of Chicago.

Q: Where did you go to college/graduate school?

I went to the University of Illinois, Urbana Champaign.

Q: What are your favorites?

Food:  Probably easier

Read More »
Industry Insights Logo

On Demand Webinar—What’s Next for Covered Entities? Navigating 340B Challenges and the Future of Patient Care

SPONSORED CONTENT

The 340B Drug Pricing Program is at a crossroads, facing increased scrutiny, manufacturer restrictions, and ongoing legal battles. In this must-watch webinar, industry experts Ted Slafsky (340B Report), Emily Cook (McDermott, Will & Emery), and Nicole Shoquist (JPS Health Network) break down the

Read More »
Industry Insights Logo

The Future of 340B in a Value-Based Care Era: Can It Survive and Thrive?

SPONSORED CONTENT

The healthcare system is undergoing a major transformation, with a growing emphasis on value-based care and outcomes-based payment models. These shifts aim to improve patient outcomes and reduce costs, fundamentally challenging traditional fee-for-service approaches. Against this backdrop, the 340B

Read More »

Expert Tip from Maxor

img
img

TIP: Use AI to optimize your health system’s 340B program.


Artificial intelligence (AI) is transforming healthcare, offering

Read More »
Industry Insights Logo

The Evolving Impact of 340B on Specialty Pharmacy

SPONSORED CONTENT

The 340B program continues to be a central topic of discussion in the pharmaceutical landscape, especially as specialty medications become an increasing portion of healthcare spending. Specialty pharmacies, covered entities (CEs), and manufacturers are navigating a complex environment shaped by regulatory updates, financial

Read More »
Industry Insights Logo

Struggling with Low Pharmacy Capture Rates?

SPONSORED CONTENT

As a pharmacist and executive pharmacy leader, I nodded in affirmation when reading McKinsey & Company describe pharmacy services as a critical source of value for health centers and hospital systems,

Read More »

Expert Tip from Maxor — Oct 2024

img
img

TIP: Covered entities must protect their 340B programs from manufacturers attempting to reduce savings and eligibility.


Read More »

340B INDUSTRY LEADER SPOTLIGHT

Jason Atlas, Senior Vice President, Pharmacy Operations, Maxor National Pharmacy Services

Jason Atlas

Q: Where did you grow up?

Princeton NJ.  My father and his twin brother owned and operated an independent pharmacy for over 40 years, and obviously pharmacy runs in the family.

Q: Where did you go to college/graduate school?

I graduated from the Ernest Mario School of Pharmacy, Rutgers University and then completed my Masters in Business Administration

Read More »
Industry Insights Logo

PBM is not a 4-letter word: How an independent PBM and an integrated pharmacy strategy provides value for your organization

SPONSORED CONTENT

Every dollar counts when you’re serving an underserved population. However, many organizations fail to incorporate a holistic approach to pharmacy and typically will separate pharmacy benefit management from pharmacy operations management. Creating an integrated pharmacy strategy

Read More »

Expert Tip from Maxor – April 2024

img
img

TIP: Improve capture rates to reach your full 340B savings potential.


From changing compliance mandates to the

Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live